Evidence map›Paper›PMID 31776643›Full record

ArticleAnalytical and bioanalytical chemistry2019

Imaging drugs, metabolites and biomarkers in rodent lung: a DESI MS strategy for the evaluation of drug-induced lipidosis.

Alex Dexter, Rory T Steven, Aateka Patel, Lea Ann Dailey, Adam J Taylor, Doug Ball, Jan Klapwijk, Ben Forbes, Clive P Page, Josephine Bunch

Open access · hybridAbstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Spatial pharmacology using mass spectrometry imaging.Trends in pharmacological sciences · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Alex DexterNational Physical Laboratory, Teddington, London, TW11 0LW, UK.
Rory T StevenNational Physical Laboratory, Teddington, London, TW11 0LW, UK.
Aateka PatelInstitute of Pharmaceutical Science, King's College London, London, WC2R 2LS, UK.
Lea Ann DaileyInstitute of Pharmaceutical Science, King's College London, London, WC2R 2LS, UK.
Adam J TaylorNational Physical Laboratory, Teddington, London, TW11 0LW, UK.
Doug BallImmunoinflammation TAU, GlaxoSmithKline, Stevenage, SG1 2NY, UK.
Jan KlapwijkImmunoinflammation TAU, GlaxoSmithKline, Stevenage, SG1 2NY, UK.
Ben ForbesInstitute of Pharmaceutical Science, King's College London, London, WC2R 2LS, UK.
Clive P PageInstitute of Pharmaceutical Science, King's College London, London, WC2R 2LS, UK.
Josephine BunchNational Physical Laboratory, Teddington, London, TW11 0LW, UK. Josephine.bunch@npl.co.uk.
King's College London · GBNational Physical Laboratory · GBGlaxoSmithKline (United Kingdom) · GBImperial College London · GBMartin Luther University Halle-Wittenberg · DE

Funding

National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/C013109/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/C013203/1
6 · The paper itself

Abstract

Within drug development and pre-clinical trials, a common, significant and poorly understood event is the development of drug-induced lipidosis in tissues and cells. In this manuscript, we describe a mass spectrometry imaging strategy, involving repeated analysis of tissue sections by DESI MS, in positive and negative polarities, using MS and MS/MS modes. We present results of the detected distributions of the administered drug, drug metabolites, lipid molecules and a putative marker of lipidosis, di-docosahexaenoyl (22:6)-bis(monoacylglycerol) phosphate (di-22:6-BMP). A range of strategies have previously been reported for detection, isolation and identification of this compound, which is an isomer of di-docosahexaenoic (22:6 n-3) phosphatidylglycerol (di-22:6 PG), a commonly found lipid that acts as a surfactant in lung tissues. We show that MS imaging using MS/MS can be used to differentiate these compounds of identical mass, based upon the different distributions of abundant fragment ions. Registration of images of these fragments, and detected drugs and metabolites, is presented as a new method for studying drug-induced lipidosis in tissues. Graphical abstract.

Indexed as

AmiodaroneAnimalsAnti-Arrhythmia AgentsBiomarkersLipidosesLungMaleMass SpectrometryRats, WistarRodentiaAmiodaroneAnti-Arrhythmia AgentsBiomarkersAmiodaroneBMPImaging mass spectrometryMass spectrometry imagingPharmaceuticals

Identifiers

PMID31776643
PMCPMC6920235
OpenAlexW2990130863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.